1. Shi, Wenwen, Huang, Qiudi, Xie, Jiacui, Yu, Xiyong, Zhou, Yi. 2020. CKS1B as Drug Resistance-Inducing Gene-A Potential Target to Improve Cancer Therapy. In Frontiers in oncology, 10, 582451. doi:10.3389/fonc.2020.582451. https://pubmed.ncbi.nlm.nih.gov/33102238/
2. Bock, Fabian, Lu, Gary, Srour, Samer A, Champlin, Richard E, Qazilbash, Muzaffar H. 2016. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. In Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2159-2164. doi:10.1016/j.bbmt.2016.09.003. https://pubmed.ncbi.nlm.nih.gov/27638366/
3. Li, Lincheng, Wang, Jing, Zhang, Zhuochao, Li, Chonghui, Liu, Rong. 2022. Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer. In Frontiers in immunology, 13, 1052768. doi:10.3389/fimmu.2022.1052768. https://pubmed.ncbi.nlm.nih.gov/36405738/
4. Liu, Xitao, Zhao, Defang. 2021. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway. In Animal cells and systems, 25, 227-234. doi:10.1080/19768354.2021.1953142. https://pubmed.ncbi.nlm.nih.gov/34408811/
5. Stella, Flavia, Pedrazzini, Estela, Baialardo, Edgardo, Schutz, Natalia, Slavutsky, Irma. 2014. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders. In Blood cells, molecules & diseases, 53, 110-7. doi:10.1016/j.bcmd.2014.05.006. https://pubmed.ncbi.nlm.nih.gov/24973170/
6. Tang, Yuzhu, Lan, Xiaohua, Yan, Maohui, Fu, Zhiguang, Li, Hongqi. . CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways. In Saudi medical journal, 45, 128-138. doi:10.15537/smj.2024.45.2.20230132. https://pubmed.ncbi.nlm.nih.gov/38309745/
7. Ye, Bicheng, Hongting, Ge, Zhuang, Wen, Jiang, Aimin, Zhong, Yating. . Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. In Journal of cellular and molecular medicine, 28, e18564. doi:10.1111/jcmm.18564. https://pubmed.ncbi.nlm.nih.gov/39046884/
8. Zhan, Fenghuang, Colla, Simona, Wu, Xiaosong, Barlogie, Bart, Shaughnessy, John D. 2007. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms. In Blood, 109, 4995-5001. doi:. https://pubmed.ncbi.nlm.nih.gov/17303695/
9. Chang, Hong, Qi, Xiaoying, Trieu, Young, Ning, Yi, Reece, Donna. 2006. Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. In British journal of haematology, 135, 486-91. doi:. https://pubmed.ncbi.nlm.nih.gov/16995883/
10. Zhang, Lianmin, Cui, Yanan, Mei, Jie, Zhang, Zhenfa, Zhang, Pengpeng. 2024. Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies. In Cell proliferation, 57, e13703. doi:10.1111/cpr.13703. https://pubmed.ncbi.nlm.nih.gov/38946232/
智鼠故事 
